Stark, F.C.; Weeratna, R.D.; Deschatelets, L.; Gurnani, K.; Dudani, R.; McCluskie, M.J.; Krishnan, L.
An Archaeosome-Adjuvanted Vaccine and Checkpoint Inhibitor Therapy Combination Significantly Enhances Protection from Murine Melanoma. Vaccines 2017, 5, 38.
https://doi.org/10.3390/vaccines5040038
AMA Style
Stark FC, Weeratna RD, Deschatelets L, Gurnani K, Dudani R, McCluskie MJ, Krishnan L.
An Archaeosome-Adjuvanted Vaccine and Checkpoint Inhibitor Therapy Combination Significantly Enhances Protection from Murine Melanoma. Vaccines. 2017; 5(4):38.
https://doi.org/10.3390/vaccines5040038
Chicago/Turabian Style
Stark, Felicity C., Risini D. Weeratna, Lise Deschatelets, Komal Gurnani, Renu Dudani, Michael J. McCluskie, and Lakshmi Krishnan.
2017. "An Archaeosome-Adjuvanted Vaccine and Checkpoint Inhibitor Therapy Combination Significantly Enhances Protection from Murine Melanoma" Vaccines 5, no. 4: 38.
https://doi.org/10.3390/vaccines5040038
APA Style
Stark, F. C., Weeratna, R. D., Deschatelets, L., Gurnani, K., Dudani, R., McCluskie, M. J., & Krishnan, L.
(2017). An Archaeosome-Adjuvanted Vaccine and Checkpoint Inhibitor Therapy Combination Significantly Enhances Protection from Murine Melanoma. Vaccines, 5(4), 38.
https://doi.org/10.3390/vaccines5040038